CHAPEL HILL, N.C., April 1, 2016 /PRNewswire/ -- It's no secret that pharmaceutical companies' revenues flow in large part from payers.
And with payers putting greater emphasis on real world evidence and value, many organizations have turned to their medical affairs group to effectively streamline the dissemination of medical information to payers. Yet this is a relatively new role for the medical affairs function and therefore some companies are struggling to identify the staffing and activity requirements for medical affairs to be successful with payer activities.
To inform these efforts and to probe current trends and best practices regarding the role of medical affairs in payer interactions, research and consulting leader Best Practices, LLC conducted a primary research project. The research project produced a benchmarking report, "Medical Affairs' Critical Role in Payer Interactions," that examines the role of medical affairs in critical payer interactions and highlights strategies for building and maintaining effective payer relationships.
The study results illustrate that this issue is clearly pushing medical affairs' leaders to adjust their staffing: 75% of the participants said they expect growth in staffing for their market access and payer activities within the next 24 months. In addition, almost a quarter of the participants expect more than 30% growth in payer and market access activity staffing. Aside from gathering current medical affairs trends around resourcing, this new study examines issues regarding structure, strategies, and training for medical affairs to effectively interact with the payer community.
This study will:
- Illustrate how leading Pharma and Biotech companies structure and organize their payer groups and Medical Affairs' involvement
- Highlight strategies for building and maintaining effective relationships with payers
- Guide Medical Affairs in talent acquisition and training for their payer groups
- Explore strategies for identifying, segmenting and prioritizing payers
Twenty-nine medical affairs leaders at 27 biopharmaceutical companies participated in this research. Responses in this study have been presented in two segments: regional (US only and global companies) and company size (large, medium-sized and small companies).
To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1422.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/current-trends-and-best-practices-for-pharmaceutical-companies-seeking-to-boost-the-role-of-medical-affairs-in-payer-interactions-300244908.html
SOURCE Best Practices, LLC